University of Thessaly (UTH)
Μελέτη παθογενετικής σημασίας διαφόρων παραμέτρων λοιμώξεως από ιό των θηλωμάτων του ανθρώπου (HPV) στην ανάπτυξη καρκίνου του τραχήλου της μήτρας: πρόδρομες αλλοιώσεις και διηθητικό καρκίνωμα
Abstract
dc:descriptionCervical cancer is the second most common type of cancer in women worldwide. High-risk human papillomavirus (HR-HPV) persistent infection is the main causative agent. The HPV-induced process of tumorigenesis is associated with well-defined clinical stages, each with unique features. HR-HPV types are present in over than 99% of cervical cancers and in the vast majority of cases with high grade cervical intraepithelial neoplasia. Therefore, it has been suggested that HPV detection might be a useful tool in identification of women who are at risk to develop cervical cancer, in addition to Pap smears. In recent years, research is being focused on both the development of HPV vaccines crucial for the prevention of cervical disease and the identification of molecular markers to be used as potential screening tools in the early detection of cervical cancer precursors. HPV type distribution presents geographical heterogeneity and most of the studies are related to HPV 16 type. Therefore, in our study we evaluated the prevalence of HPV infection among 134 Greek women with Pap test abnormalities, who visited the external colposcopy clinic of the University General Hospital of Larissa between 2008 and 2010. The majority of the women completed a questionnaire about their age, educational level, smoking habits, previous abnormal Pap test or previous infection from HPV virus or Chlamydia trachomatis. Both cervical smears and biopsies were collected. A biopsy sample was not collected from 11 women, thus they were excluded from the study. Biopsies were histological diagnosed and 3 women diagnosed with inflammation and 2 more having only endocervical mucosa in their biopsy were further excluded. Biopsies and cervical smears were further analyzed for HPV presence. DNA was extracted and PCR amplification was performed. A specific L1 HPV region was amplified with consensus PGMY primer set. Specific primers for low-risk HPV types 6, 11 and high-risk HPV types 16, 18, 31 and 33 were also used. Immunohistochemistry (IHC) was also performed in order to evaluate expression patterns of p16, cyclin B1 and MIB-1 markers. These cellular proteins are thought to be surrogate biomarkers for persistent infection with high-risk HPV viruses. Statistical analysis of the questionnaires did not reveal significant associations (p< 0.05 was considered statistically significant) for any of the parameters included except for smoking habits. High grade dysplasia lesions were much more frequent in smokers than non smokers (p=0,020). However, in a multiple logistic regression model, evaluating all parameters, smoking cease to be statistically important, supporting its synergistic action to the existing HPV infection.Based on histological diagnosis 87 women had low grade squamous intraepithelial lesion (LGSIL), 28 women showed high grade squamous intraepithelial lesion (HGSIL) and 3 women had cancer. HPV virus was present in 90,81% of LGSIL samples (79/87 women). HPV was present in all HGSIL and cancer cases. 110/118 samples (93,22%) were HPV positive. Positive samples were further analyzed for HPV typing. In both LGSIL and HGSIL biopsies the most common HPV types were 16, 18, 31 and 33. Low-risk 6, 11 HPV types were also present at multiple infections. It is worth mentioning that HPV51 was present in LGSILs, while HPV59 was more frequent in HGSIL cases. We also examined the frequency of simple and multiple HPV infections in our samples. In our study, 21% of LGSIL cases showed multiple infections, while in HGSIL cases almost half of them had multiple HPV infection. Differences in the frequencies of simple and multiple HPV infections have been mentioned before suggesting that both geographical heterogeneity and different methodological approaches could be responsible. Multiple HPV infections are more frequent in women aged less than 35 years old. Immunohistochemistry was performed for p16, cyclin-B1 and MIB-1 evaluation. Samples positive for p16 staining were classified in four groups (patterns A, A low, B, C). 78,2% of LGSIL and 96,43% of HGSIL cases and all 3 of the cancers showed positive p16 staining. However, there were differences in the expression patterns, since the majority of LGSIL cases showed focal p16 staining (A, A low patterns), while diffuse staining (patterns B, C) was present in 92,86% of HGSIL cases and in 100% of cancers. Samples were classified in three groups (patterns A, B, C) for cyclin-B1 evaluation. Pattern A was characterized as negative, while patterns B, C were characterized as positive. 94,07% of the samples showed positive staining for cyclin- B1. All HGSIL cases and cancers showed B and C patterns for cyclin-B1. In LGSIL cases, positive staining for cyclin-B1 was present in 91,95% (80/87 women). The majority of LGSIL cases showed pattern B, while the majority of HGSIL cases showed pattern C.For MIB-1 staining evaluation, samples were also classified in three groups (patterns 1/3, 2/3, 3/3). LGSIL cases presented mostly pattern 1/3, while the majority of HGSIL cases presented patterns 2/3 and 3/3. All 3 cancers showed pattern 3/3 for MIB-1 staining. Statistical analysis of the results obtained by immunohistochemistry showed significant correlations between p16 (pattern C), cyclin-B1 (pattern C) and MIB-1 (pattern 3/3) staining and the degree of dysplasia (HGSIL cases) (p<0,05). Correlations between p16, cyclin-B1 and MIB-1 protein expression patterns with HPV presence were further evaluated. Statistical analysis revealed significant correlation between diffuse p16 staining (pattern C) and multiple HPV infection (p=0,005), as well as with HPV16 type (p=0,015). Correlation between cyclin-B1 staining (patterns B, C) and multiple HPV infection showed analogous results (p=0,04). There was no significant correlation for cyclin B1 staining and high-risk HPV types such as HPV16, HPV18 (p=0,105). Finally, MIB-1 pattern 1/3 was present mostly in simple infections (p=0,001) and there was no significant correlation between MIB-1 immunostaining and high-risk HPV16 and HPV18 types (p=0,085). However, evaluation in a larger group is needed.In conclusion, ιmmunostaining for p16, cyclin-B1 and MIB-1 seems to have a supportive role in histological diagnosis which remains the “gold standard” in the evaluation of cervical lesions so that patients receive appropriate treatment.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Zacharouli, Konstantina
- Ζαχαρούλη, Κωνσταντίνα
Subjects
dc:subject × 24- Ιός των θηλωμάτων του ανθρώπου (HPV)
- Δυσπλασία τραχήλου μήτρας υψηλού βαθμού
- Δυσπλασία τραχήλου μήτρας χαμηλού βαθμού
- Καρκίνος τραχήλου μήτρας
- Γονιδίωμα
- Κυτταρικός κύκλος
- Πρωτεΐνες
- Ανίχνευση μοριακή
- Τυποποίηση HPV λοίμωξης
- Ανοσοϊστοχημικοί δείκτες
- Human papilloma virus (HPV)
- High grade dysplasia
- Low grade dysplasia
- Cervical cancer
- Genome
- Cell cycle
- Proteins
- Molecular detection
- HPV typing
- Immunohistochemical markers
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/36129